Evaluation of Time-to-event Surrogate Endpoint Endpoint ─Meta-analytic Approach─-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of Time-to-event Surrogate Endpoint Endpoint ─Meta-analytic Approach─

Published:2024-07-30 Issue:1 Volume:45 Page:67-85
ISSN:0918-4430
Container-title:Japanese Journal of Biometrics
language:en
Short-container-title:JJB

Author:

Emura Takeshi¹²³,Oba Koji⁴⁵

Affiliation:

1. Department of Fundamental Statistical Mathematics, the Institute of Statistical Mathematics

2. Research Center for Medical and Health Data Science,the Institute of Statistical Mathematics

3. Biostatistics Center, Kurume University

4. Interfaculty Initiative in Information Studies, the University of Tokyo

5. Department of Biostatistics, School of Public Health, Graduate School of Medicine, the University of Tokyo

Publisher

The Biometric Society of Japan

Link

https://www.jstage.jst.go.jp/article/jjb/45/1/45_67/_pdf

Reference61 articles.

1. Alonso, A., Bigirumurame, T., Burzykowski, T. et al. (2016). Applied Surrogate Endpoint Evaluation Methods with SAS and R. CRC Press.

2. Alonso, A. and Molenberghs, G. (2008). Evaluating time to cancer recurrence as a surrogate marker for survival from an information theory perspective. Statistical Methods in Medical Research, 17(5), 497-504.

3. Belaroussi, Y., Bouteiller, F., Bellera, C. et al. (2023). Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting. Scientific Reports, 13(1), 9584.

4. Bellera. C.A., Penel, N., Ouali, M. et al. (2014). Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Annals of Oncology, 26(5), 865-872.

5. Bellera, C. A., Pulido, M., Gourgou, S. et al. (2013). Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials. European Journal of Cancer, 49(4), 769-781.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3